-
| Exchange | PINK |
|---|---|
| CurrencyCode | USD |
| ISIN | US6760791060 |
| Sector | Financial Services |
| Industry | Shell Companies |
| Beta | -0.06 |
|---|---|
| Market Cap | 8M |
| PE Ratio | None |
| Target Price | 4 |
| Dividend Yield | None |
Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ODTC using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025